Interleukine 6 as a Predictor of Outcome in Mechanically Ventilated Patients With Covid 19

NCT05274503 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2022-03-10

No results posted yet for this study

Summary

Serum IL-6 levels will be determined by enzyme-linked immunosorbent assay according to the manufacturer's instructions and the normal range is \<10 pg/mL , Patients' medical records will be carefully reviewed and analyzed. Patient data regarding demographics, comorbidities, signs and symptoms, laboratory results and complications will be collected. The occurrence of complications will be confirmed according to the following criteria: acute respiratory distress syndrome (ARDS) defined according to the Berlin definition

Conditions

  • Mechanical Ventilation Duration

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2021-12-01
Completion
2022-01-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05274503 on ClinicalTrials.gov